Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies

J Lalani, M Rathi, M Lalan, A Misra - Drug development and …, 2013 - Taylor & Francis
Poly (d, l-lactide-co-glycolide acid)(PLGA) Nanoparticles (NPs) with sustained drug release
and enhanced circulation time presents widely explored non-invasive approach for drug …
被引用次数：43 相关文章

Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies

J Lalani, M Rathi, M Lalan… - Drug development and …, 2013 - pubmed.ncbi.nlm.nih.gov
Poly (d, l-lactide-co-glycolide acid)(PLGA) Nanoparticles (NPs) with sustained drug release
and enhanced circulation time presents widely explored non-invasive approach for drug …
[PDF] researchgate.net

[PDF][PDF] Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies

J Lalani, M Rathi, M Lalan, A Misra - 2012 - researchgate.net
Abstract Poly (D, L-lactide-co-glycolide acid)(PLGA) Nanoparticles (NPs) with sustained
drug release and enhanced circulation time presents widely explored non-invasive …

Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.

J Lalani, M Rathi, M Lalan, A Misra - Drug Development and …, 2012 - europepmc.org
Poly (d, l-lactide-co-glycolide acid)(PLGA) Nanoparticles (NPs) with sustained drug release
and enhanced circulation time presents widely explored non-invasive approach for drug …

Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies

J Lalani, M Rathi, M Lalan, A Misra - Drug Development and Industrial …, 2013 - hero.epa.gov
Abstract Poly (d, l-lactide-co-glycolide acid)(PLGA) Nanoparticles (NPs) with sustained drug
release and enhanced circulation time presents widely explored non-invasive approach for …